ARTICLE | Clinical News
Gepirone ER regulatory update
November 12, 2007 8:00 AM UTC
The partners said FDA issued a not approvable letter for an NDA for gepirone extended-release tablets to treat adults with major depressive disorder. A 2004 not approvable letter for the serotonin (5...